WDNA – WisdomTree BioRevolution Fund
WisdomTree BioRevolution Fund (WDNA) is a Health ETF, issued by WisdomTree, $2.8M in assets, 0.45% expense ratio.
Returns as of Oct 23, 2026: 1 week +3.3%, 1 year +30.1%.
BioRevolution: Samples index of global companies transformed by genetics and biotechnology advancements.
Top holdings
- GPCR – Structure Therapeutics Inc. American Depositary Shares, 3.7%
- MRNA – Moderna Inc, 3.3%
- NTRA – Natera Inc, 2.9%
- LLY – Eli Lilly and Company, 2.8%
- JNJ – Johnson & Johnson, 2.7%
- PFE – Pfizer Inc, 2.4%
- BNTX – BioNTech SE, 2.4%
- BEAM – Beam Therapeutics Inc, 2.3%
- 0QIU – Novo Nordisk A/S Class B, 2.3%
- STOK – Stoke Therapeutics Inc, 2.2%
- UTHR – United Therapeutics Corporation, 2.1%
- AMGN – Amgen Inc, 2.1%
- FOLD – Amicus Therapeutics Inc, 2.1%
- RGNX – Regenxbio Inc, 2.1%
- AZN – AstraZeneca PLC ADR, 2.1%
- CRSP – Crispr Therapeutics AG, 2.0%
- IONS – Ionis Pharmaceuticals Inc, 2.0%
- NSIS-B – Novonesis (Novozymes) A/S, 2.0%
- TWST – Twist Bioscience Corp, 1.9%
- IMNM – Immunome Inc, 1.9%
- TXG – 10X Genomics Inc, 1.7%
- KRYS – Krystal Biotech Inc, 1.6%
- GILD – Gilead Sciences Inc, 1.6%
- EXAS – EXACT Sciences Corporation, 1.5%
- NOVN – Novartis AG, 1.5%